JP2005531486A5 - - Google Patents

Download PDF

Info

Publication number
JP2005531486A5
JP2005531486A5 JP2003519096A JP2003519096A JP2005531486A5 JP 2005531486 A5 JP2005531486 A5 JP 2005531486A5 JP 2003519096 A JP2003519096 A JP 2003519096A JP 2003519096 A JP2003519096 A JP 2003519096A JP 2005531486 A5 JP2005531486 A5 JP 2005531486A5
Authority
JP
Japan
Prior art keywords
amino
methyl
salt
hydride
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003519096A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005531486A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/024896 external-priority patent/WO2003014147A1/en
Publication of JP2005531486A publication Critical patent/JP2005531486A/ja
Publication of JP2005531486A5 publication Critical patent/JP2005531486A5/ja
Pending legal-status Critical Current

Links

JP2003519096A 2001-08-06 2002-08-06 新規のデプシペプチドおよびこれを調製するためのプロセス Pending JP2005531486A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31031301P 2001-08-06 2001-08-06
PCT/US2002/024896 WO2003014147A1 (en) 2001-08-06 2002-08-06 Novel depsipeptides and process for preparing same

Publications (2)

Publication Number Publication Date
JP2005531486A JP2005531486A (ja) 2005-10-20
JP2005531486A5 true JP2005531486A5 (https=) 2006-01-05

Family

ID=23201948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003519096A Pending JP2005531486A (ja) 2001-08-06 2002-08-06 新規のデプシペプチドおよびこれを調製するためのプロセス

Country Status (15)

Country Link
US (5) US20030083240A1 (https=)
EP (2) EP1423414A4 (https=)
JP (1) JP2005531486A (https=)
KR (1) KR20040022233A (https=)
CN (1) CN100352836C (https=)
AT (1) ATE430160T1 (https=)
AU (1) AU2002353775A1 (https=)
BR (1) BR0211761A (https=)
CA (2) CA2456323A1 (https=)
DE (1) DE60232158D1 (https=)
IL (1) IL160171A0 (https=)
NZ (1) NZ531493A (https=)
RU (1) RU2348647C2 (https=)
WO (2) WO2003017924A2 (https=)
ZA (1) ZA200400928B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211761A (pt) * 2001-08-06 2007-01-09 Cubist Pharm Inc depsipeptìdeos e processos para preparar os mesmos
US6767718B2 (en) * 2002-05-10 2004-07-27 Biosource Pharm, Inc. Lipodepsipeptide antibiotics and methods of preparation
AU2004246909B2 (en) * 2003-06-19 2010-08-19 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
CA2587848A1 (en) * 2004-11-12 2006-10-19 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides
WO2006063132A2 (en) * 2004-12-06 2006-06-15 The Regents Of The University Of California Methods for improving the structure and function of arterioles
EP1877041A2 (en) * 2005-04-29 2008-01-16 Cubist Pharmaceuticals, Inc. Therapeutic compositions
JP5607025B2 (ja) * 2008-04-21 2014-10-15 シグナム バイオサイエンシーズ, インコーポレイテッド 化合物、組成物およびそれらを作製する方法
PL2379580T3 (pl) 2008-12-22 2014-05-30 Merck Sharp & Dohme Nowe środki przeciwbakteryjne do leczenia zakażeń wywołanych bakteriami Gram-dodatnimi
CA2747995A1 (en) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CN101899094B (zh) * 2009-06-01 2012-11-21 安徽丰原发酵技术工程研究有限公司 一种高纯达托霉素的制备方法
KR101013755B1 (ko) * 2010-02-02 2011-02-14 주식회사 삼광산전 정출력용 엘이디모듈 전원공급 컨버터
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CN102351775B (zh) * 2011-09-14 2013-10-09 佛山普正医药科技有限公司 一种左旋5-羟基色氨酸的制备方法
WO2013059610A1 (en) 2011-10-20 2013-04-25 Trius Therapeutics, Inc. Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
TW202244057A (zh) * 2012-12-03 2022-11-16 美商諾維生物製藥有限公司 新穎縮肽及其用途
JP6634197B2 (ja) * 2013-05-08 2020-01-22 株式会社ゲノム創薬研究所 固相レジンを用いた環状ペプチド化合物の製造方法
WO2015172047A1 (en) * 2014-05-08 2015-11-12 Merck Sharp & Dohme Corp. Cyclic peptide compounds and related methods, salts and compositions
KR101671325B1 (ko) * 2015-01-09 2016-11-02 한국생명공학연구원 신규한 고리형 뎁시펩타이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 항균용 약학적 조성물
US11667674B2 (en) * 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US11643438B2 (en) 2018-07-20 2023-05-09 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
USRE32310E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
USRE32311E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4885243A (en) 1984-10-09 1989-12-05 Eli Lilly And Company Process for producing A-21978C derivatives
US4800157A (en) * 1985-09-09 1989-01-24 Eli Lilly And Company Process for producing the A-21978C antibiotics
CA1315229C (en) * 1987-06-10 1993-03-30 Eli Lilly And Company Chromatographic purification process
US4874843A (en) * 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US4994270A (en) * 1988-04-11 1991-02-19 Eli Lilly And Company A54145 antibiotics and process for their production
US5028590A (en) * 1988-04-11 1991-07-02 Eli Lilly And Company Derivatives of A54145 cyclic peptides
IL98349A (en) * 1990-06-07 1995-05-26 Lilly Co Eli Diphylase lipopeptide
CA2131389A1 (en) * 1992-03-02 1993-09-16 John M. Maraganore Thrombin receptor antagonists
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US6010861A (en) * 1994-08-03 2000-01-04 Dgi Biotechnologies, Llc Target specific screens and their use for discovering small organic molecular pharmacophores
JP3123078B2 (ja) 1996-03-08 2001-01-09 藤沢薬品工業株式会社 環状リポペプチド物質の脱アシル化法
US5958728A (en) * 1996-11-18 1999-09-28 Novo Nordiskbiotech, Inc. Methods for producing polypeptides in mutants of bacillus cells
US20010041346A1 (en) 1999-07-14 2001-11-15 Michael E. Mendelsohn Method for assaying compounds affecting smooth muscle contractile state
AU784812B2 (en) 1999-12-15 2006-06-29 Merck Sharp & Dohme Corp. Lipopeptides as antibacterial agents
CA2394313A1 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Novel lipopeptides as antibacterial agents
MXPA02006029A (es) 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos novedosos como agentes antibacterianos.
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6750199B2 (en) * 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
BR0211761A (pt) 2001-08-06 2007-01-09 Cubist Pharm Inc depsipeptìdeos e processos para preparar os mesmos

Similar Documents

Publication Publication Date Title
JP2005531486A5 (https=)
RU2004106630A (ru) Новые депсипептиды и способы их получения
JP2007501809A5 (https=)
JP2005511699A5 (https=)
RU2214398C2 (ru) Производное циклоалкена, способ его получения (варианты), фармацевтическая композиция, способ ингибирования, способ профилактики или лечения
JP2020169171A5 (https=)
PT78633A (de) Verfahren zur herstellung von optisch aktiven carbazol derivaten neue r-und s-carbazol-derivate sowie arzneimittel die diese verbindungen enthalten
KR920008065A (ko) 펩타이드 화합물, 그의 제조 방법 및 그를 함유하는 약제학적 조성물
RU2007123235A (ru) Противоопухолевые соединения
RU98100107A (ru) Замещенные липосахариды, используемые для лечения и профилактики эндотоксикоза
RU99105564A (ru) Способ получения соединений ряда эстеинасцидина
CA2458632A1 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
RU95113148A (ru) Производное 2-(2-амино-1,6-дигидро-6-оксопурин-9-ил)-метокси-1,3-пропандиола
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2005536503A5 (https=)
JP2004517098A5 (https=)
JP2003502367A5 (https=)
JP2010505865A5 (https=)
CA2539738A1 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
RU2005121927A (ru) Производные безводного кристаллического азидоцитозинполусульфата
RU2002123641A (ru) С-4 карбонатсодержащие таксаны
JP2009520695A5 (https=)
RU2003134629A (ru) Соединения цефема
RU2004102398A (ru) Производные бензо[g]хинолина для лечения глаукомы и близорукости
RU2009122481A (ru) Эффективный способ получения соединений мугеиновой кислоты